Ifp Advisors, Inc Leap Therapeutics, Inc. Transaction History

Ifp Advisors, Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 06, 2021	SELL	$1.35 - $4.01 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$1.48 - $1.92 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	BUY	$1.82 - $3.01 $0 - $0	0 New	0 $0
Q4 2020 Jan 25, 2021	BUY	$1.49 - $2.37 $0 - $0	0 New	0 $0
Q3 2020 Oct 29, 2020	BUY	$1.68 - $2.17 $0 - $0	0 New	0 $0
Q2 2020 Aug 05, 2020	BUY	$1.39 - $2.84 $0 - $0	0 New	0 $0
Q1 2020 May 12, 2020	BUY	$1.06 - $2.94 $0 - $0	0 New	0 $0
Q2 2018 Aug 07, 2018	SELL	$6.76 - $10.01 $1,690 - $2,502	-250 Closed	0 $0
Q1 2018 Jun 03, 2019	BUY	$6.06 - $8.54 $1,515 - $2,135	250 New	250 $2,000
Q1 2018 May 09, 2018	SELL	$6.06 - $8.54 $1,515 - $2,135	-250 Closed	0 $0
Q4 2017 Jan 24, 2018	BUY	$4.99 - $7.3 $1,247 - $1,825	250	250 $0

265K

Ticker LPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,021,400
Market Cap $275M
Description
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate can...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.